Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Blake Nordblad"'
Autor:
Haoran Li, Kamal Kant Sahu, Shruti Adidam Kumar, Nishita Tripathi, Nicolas Sayegh, Blake Nordblad, Beverly Chigarira, Sumati Gupta, Benjamin L. Maughan, Neeraj Agarwal, Umang Swami
Publikováno v:
Cancers, Vol 15, Iss 21, p 5171 (2023)
Compared to the urban population, patients in rural areas face healthcare disparities and experience inferior healthcare-related outcomes. To compare the healthcare quality metrics and outcomes between patients with advanced genitourinary cancers fro
Externí odkaz:
https://doaj.org/article/eaf7be66ca8d4829a72627d403ed9483
Autor:
Haoran Li, Kamal Kant Sahu, Shruti Adidam Kumar, Blake Nordblad, Nicolas Sayegh, Nishita Tripathi, Vinay Mathew Thomas, Sumati Gupta, Benjamin L. Maughan, Neeraj Agarwal, Umang Swami
Publikováno v:
Heliyon, Vol 8, Iss 9, Pp e10583- (2022)
Background: COVID-19 vaccination is one of the pivotal key tools against the ongoing pandemic, but its acceptance relies on efficacy and safety data among various populations, including patients with cancers. However, there is limited data on serocon
Externí odkaz:
https://doaj.org/article/8436bd9676a84a87929abb313c09f0f8
Autor:
Haoran Li, Nishita Tripathi, Nicolas Sayegh, Jackson Cheney, Blake Nordblad, Beverly Chigarira, Umang Swami, Sumati Gupta, Benjamin L. Maughan, Neeraj Agarwal
Publikováno v:
Journal of the National Comprehensive Cancer Network. 20:HSR22-151
Autor:
Haoran Li, Nishita Tripathi, Nicolas Sayegh, Jackson Cheney, Blake Nordblad, Beveerly Chigarira, Umang Swami, Sumati Gupta, Benjamin L Maughan, Neeraj Agarwal
Publikováno v:
International Journal of Cancer Care and Delivery. 2
Autor:
Umang Swami, Beverly Chigarira, Nicolas Sayegh, Taylor Ryan McFarland, Nishita Tripathi, Roberto Nussenzveig, Adam Kessel, Clara Tandar, Divyam Goel, Jackson Cheney, Blake Nordblad, Vinay Mathew Thomas, Deepika Sirohi, Benjamin L. Maughan, Neeraj Agarwal
Publikováno v:
International Journal of Cancer Care and Delivery. 2
133 Background: In the PEACE-1 trial (Fizazi, ESMO 2021), in pts with dn-hv-mCSPC, the addition of abiraterone to ADT + docetaxel (triplet therapy arm) resulted in a median OS of 61 months (OS on ADT + docetaxel arm was 42 months). However, independe
Autor:
Nicolas Sayegh, Beverly Chigarira, Edgar Javier Hernandez, Taylor Ryan McFarland, Haoran Li, Kamal Kant Sahu, Nishita Tripathi, Shruti Adidam Kumar, Blake Nordblad, Divyam Goel, Clara Tandar, Mark Yandell, Roberto Nussenzveig, Deepika Sirohi, Benjamin L. Maughan, Umang Swami, Neeraj Agarwal
Publikováno v:
International Journal of Cancer Care and Delivery. 2
5080 Background: Pts with DN-mCSPC have been reported to experience worse prognosis and outcomes compared to those with PLT-mCSPC. We hypothesized that gene expression profiling of pre-treatment primary prostate tumors from PLT-mCSPC pts would be dis
Autor:
Jennifer Lloyd, Blake Nordblad, Kamal Kant Kant Sahu, Umang Swami, Tenzin Kunsang Phunrab, Julia Anne Batten, Lindsay Maxwell, Manish Kohli, Sumati Gupta, Benjamin L. Maughan, Neeraj Agarwal
Publikováno v:
Journal of Clinical Oncology. 41:105-105
105 Background: In clinical trials, treatment efficacy rates are based on participants who can tolerate treatment through study endpoints. Attrition from clinical trials can potentially lead to biased results (PMID: 30379822). Many oncology clinical
Autor:
Haoran Li, Kamal Kant Kant Sahu, Georges Gebrael, Beverly Chigarira, Vinay Mathew Thomas, Yeonjung Jo, Shruti Adidam Kumar, Blake Nordblad, James Brundage, Nishita Tripathi, Nicolas Sayegh, Umang Swami, Neeraj Agarwal, Benjamin L. Maughan
Publikováno v:
Journal of Clinical Oncology. 41:726-726
726 Background: VTE is a common complication in pts with mRCC. Identifying pts with mRCC at the highest risk of developing VTE may provide the rationale for initiating prophylactic anticoagulation. Methods: In this IRB-approved retrospective study, p
Autor:
Nishita Tripathi, Yeonjung Jo, Nicolas Sayegh, Beverly Chigarira, Blake Nordblad, Vinay Mathew Thomas, Benjamin Haaland, Roberto Nussenzveig, Sumati Gupta, Neeraj Agarwal, Umang Swami, Benjamin L. Maughan
Publikováno v:
Cancer Research. 82:5995-5995
Background: Presence of liver metastasis is associated with a poor prognosis in mUC. According to the prognostic model by Sonpavde et. al, post platinum treated mUC pts with liver metastasis had a 50% higher risk of death on immunotherapy compared to
Autor:
Nishita Tripathi, Haoran Li, Yeonjung Jo, Nicolas Sayegh, Clara Tandar, Roberto Nussenzveig, Benjamin Haaland, Jackson Cheney, Divyam Goel, Blake Nordblad, Sumati Gupta, Benjamin L. Maughan, Neeraj Agarwal, Umang Swami
Publikováno v:
Journal of Clinical Oncology. 40:373-373
373 Background: Renal cell carcinoma is predominant in 6th to 8th decade of life. Younger pts are more likely to have symptomatic tumors on presentation but with favorable pathological features and disease specific survival (PMID: 17092632). Herein,